Switzerland's news in English

Editions:  Europe · Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland

Roche extends hostile $5.7 billion Illumina bid

Share this article

Roche extends hostile $5.7 billion Illumina bid
12:53 CEST+02:00

Swiss pharmaceutical giant Roche on Monday extended its hostile $5.7 billion bid for US gene mapper Illumina by four weeks.

"Roche announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc., at a price of $44.50 per share, to 6:00 p.m., New York City time, on April 20th, 2012," the Basel-based group said.

The group's previous offer ran until March 23rd, but it has so far only received shares worth about $6.4 million.

Roche claims that its offer is 64 percent higher than Illumina's closing price on December 21st, 2011 -- "the day before market rumours" of the bid sent the stock higher.

But Illumina, a provider of integrated systems for DNA sequencing, had opposed the hostile bid, saying it "does not reflect Illumina's unique leadership position, business performance and future prospects."

Get notified about breaking news on The Local

Share this article

The Local is not responsible for content posted by users.
Become a Member or sign-in to leave a comment.

From our sponsors

VIDEO: Three surprising facts that will make you want to visit Malta

Game of Thrones has ended but it lives on in Malta! Find out how and learn two more unexpected facts about this little archipelago in the middle of the Med.